Royal Bank of Canada Boosts Holdings in DaVita Inc. $DVA

Key Points

• Royal Bank of Canada increased its holdings in DaVita Inc. by 12.0% during the 1st quarter, acquiring an additional 24,568 shares, bringing its total ownership to 228,624 shares valued at approximately $34.97 million.
• Wall Street analysts have shown a mixed outlook on DaVita, with ratings ranging from "hold" to "buy," and a consensus price target of $164.00 highlighted by various research firms.
• In its most recent earnings report, DaVita reported $2.95 EPS, exceeding expectations, and anticipates earnings for FY 2025 to be between 10.200-11.300 EPS.

Royal Bank of Canada grew its stake in DaVita Inc. (NYSE:DVA - Free Report) by 12.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 228,624 shares of the company's stock after buying an additional 24,568 shares during the quarter. Royal Bank of Canada owned 0.30% of DaVita worth $34,972,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Fifth Third Bancorp lifted its holdings in shares of DaVita by 5.0% in the 1st quarter. Fifth Third Bancorp now owns 4,274 shares of the company's stock valued at $654,000 after buying an additional 204 shares during the period. Concurrent Investment Advisors LLC acquired a new position in shares of DaVita in the 1st quarter valued at about $223,000. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of DaVita by 22.5% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 4,351 shares of the company's stock valued at $666,000 after buying an additional 800 shares during the period. Envestnet Asset Management Inc. grew its position in shares of DaVita by 7.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 55,255 shares of the company's stock valued at $8,452,000 after acquiring an additional 4,048 shares during the period. Finally, OneDigital Investment Advisors LLC acquired a new stake in shares of DaVita during the 1st quarter valued at about $200,000. Institutional investors and hedge funds own 90.12% of the company's stock.

Insiders Place Their Bets

In other DaVita news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. This trade represents a 8.28% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.50% of the company's stock.

Wall Street Analyst Weigh In

DVA has been the topic of a number of analyst reports. Bank of America dropped their target price on DaVita from $145.00 to $140.00 and set an "underperform" rating on the stock in a research report on Wednesday. Truist Financial set a $148.00 target price on DaVita in a research report on Friday, August 8th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a research report on Friday, August 22nd. Finally, Barclays dropped their target price on DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 7th. Three analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Reduce" and a consensus price target of $158.00.

DaVita Price Performance

DVA traded down $4.42 on Wednesday, reaching $132.29. 605,120 shares of the company's stock were exchanged, compared to its average volume of 852,129. The stock has a market cap of $9.46 billion, a PE ratio of 13.01, a P/E/G ratio of 0.96 and a beta of 1.13. DaVita Inc. has a twelve month low of $126.07 and a twelve month high of $179.60. The stock's fifty day moving average price is $139.04 and its 200-day moving average price is $141.73. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.39 and a quick ratio of 1.34.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping analysts' consensus estimates of $2.70 by $0.25. The firm had revenue of $3.38 billion for the quarter, compared to analyst estimates of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. DaVita's quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the business posted $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Sell-side analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.